Restoring Skin Pigmentation in Vitiligo With Advanced Treatments

Drs Brittany Craiglow and Nada Elbuluk review the precipitating factors that trigger vitiligo, as well as segmental vs nonsegmental vitiligo.

Ted Lain, MD, breaks down the use of the Vitiligo Area Scoring Index calculations to assess vitiligo severity.

Heather Woolery-Lloyd, MD, comments on the emotional impact of vitiligo on patients’ quality of life.

Expert dermatologists share approaches to treating patients with vitiligo, focusing on patient communication and the use of combination therapy.

Ted Lain, MD, reviews the rates and patterns of repigmentation of the skin in vitiligo and how the timeline is different for each patient.

Brittany Craiglow, MD, discusses the lengthy nature of vitiligo treatment response and how to approach communicating with patients who want to see change quickly.

Experts in dermatology review the mechanism of action and clinical trials of topical ruxolitinib for repigmenting the skin in vitiligo.

Expert dermatologists comment on the impact of UV light exposure on areas of the skin with vitiligo and their recommendations for sunscreen use.

Heather Woolery-Lloyd, MD, discusses the adverse event profile of topical ruxolitinib for treatment of vitiligo, highlighting the well-tolerated nature of the drug.

Experts in dermatology share their impressions of ruxolitinib and approaches to vitiligo treatment in clinical practice.

Nada Elbuluk, MD, and Ted Lain, MD, compare response to conventional treatment options vs emerging therapies, such as ruxolitinib, in the treatment of vitiligo.

Expert dermatologists discuss the impact of vitiligo and vitiligo treatment on quality of life.

Heather Woolery-Lloyd, MD, and Nada Elbuluk, MD, share approaches to patient education and managing patient expectations when repigmenting the skin in vitiligo.

Experts in dermatology comment on the need to promote access to emerging treatments in vitiligo.

Expert dermatologists share final thoughts on treatment of vitiligo and topical ruxolitinib.